司太立(603520.SH)：钆喷酸葡胺注射液获得药品注册证书

Group 1 - The core point of the article is that the company Sital (603520.SH) has received approval from the National Medical Products Administration for its gadopentetate dimeglumine injection, which is primarily used for magnetic resonance imaging of various organs and tissues in the human body [1] Group 2 - The approved drug is indicated for use in central nervous system imaging, including the brain and spinal cord, as well as abdominal, thoracic, pelvic, and limb imaging [1]